Relation of serum ghrelin and leptin levels to blood gases disturbance in obesity hypoventilation syndrome patients Source: Annual Congress 2009 - Noninvasive ventilation: new and old aspects Year: 2009
The changes of serum adipocytokines levels in patients with OSAHS Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011
Serum leptin levels in obese patients with severe obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
The relationship of plasma adropin levels in pediatric obese patients with OSA Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children Year: 2019
Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004
Plasma leptin in asthma patients with steroid induced diabetes compared with obesity patients Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007
The impact of serum leptin and soluble leptin receptor (sOB-R) levels on respiratory chemosensitivities in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006
Association between plasma leptin levels and obstructive sleep apnoea in non-obese patients with coronary artery disease and response to CPAP treatment Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019
Serum levels of circulating adipocytokines, leptin and adiponectin, in obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 692s Year: 2004
Endothelin-1 levels, respiratory drive and hypercapnic response in obese patients with or without obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010
Impact of obstructive sleep apnoea on insulin resistance in nonobese and obese children Source: Eur Respir J 2016; 47: 1152-1161 Year: 2016
Cardiovascular and metabolic effects of CPAP in obese males with OSA Source: Eur Respir J 2007; 29: 720-727 Year: 2007
Differences in levels of systemic inflammation markers between obese subjects with or without obstructive sleep apnea Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Metabolic and inflammatory profile in obese and non obese children with obstructive breathing disorders Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Comparison between obese OSAHS adults with and without hypoventilation Source: Eur Respir J 2003; 22: Suppl. 45, 182s Year: 2003
The impact of OSA on nocturnal hypoxia in obese patients with chronic asthma Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012
Ghrelin, leptin and adiponectin plasma levels in sleep apnea patients with and without excessive daytime sleepiness Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010
Elevated leptin is associated with impaired glucose tolerance in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 573s Year: 2006
Effect of 8 week CPAP therapy on insulin resistance, serum leptin and lipid concentrations among obstructive sleep apnea hypopnea syndrome (OSAS) patients Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004
The role of leptin and adiponectin in patients with COPD Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009